OpenAlex
PricingAboutJobs
Log inGet started
Work

A randomized controlled trial of adjuvant immunotherapy (murine monoclonal antibody 494/32) in resectable pancreatic cancer

HTML

Year: 1991
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Cancer
DOI: 10.1002/1097-0142(19911001)68:7<1507::aid-cncr2820680707>3.0.co;2-0
Authors: Markus Büchler, Helmut Friess, Karl-Heinz Schultheiss, Christoph Gebhardt, Robert Kübel, Karl-Heinz Muhrer, Martin Winkelmann, Theo Wagener, Rainer Klapdor, Martin Kaul, Günther Müller, Gregor Schulz, Hans G. Beger
Institutions: Universität Ulm, Nuremberg Hospital, Heinrich Heine University Düsseldorf, Universität Hamburg, Behringwerke (Germany)
Language: English

Topic: Pancreatic and Hepatic Oncology Research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: resectable pancreatic cancer, adjuvant immunotherapy, passive immunotherapy, antibody-dependent cellular cytotoxicity, Whipple resection, survival, treatment toxicity
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2046614423
FWCI: 2.26
Cites: 52
Cited by: 94
Related to: 9
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security